Skip to main content
FinSpry Logo
FinSpry
ASND logo
ASND
(NASDAQ)
Ascendis Pharma A/S
$218.06-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ascendis Pharma A/S (ASND) Stock Price & Financial Analysis

Ascendis Pharma A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$208.00 - $219.28
52-Week High$250.74
52-Week Low$160.86
Open$209.72
Volume546.62K
Average Volume (3M)588.90K
Market Cap12.71B
Shares Outstanding60.61M
Price to Sales (P/S)15.27
Price to Book (P/B)-67.54
EV/EBITDA-61.28
Revenue (TTM)832.67M
Net Income (TTM)-263.67M
Free Cash Flow (TTM)52.51M
EPS (TTM)$-4.29
Profit Margin-31.67%
Operating Margin-19.40%
50-Day MA$231.82
200-Day MA$217.04
52-Week Change25.55%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ascendis Pharma A/S

What is the current stock price for ASND?

As of the latest trading session, ASND stock trades at $215.60. The 52-week range is $160.86–$250.74, with a day range of $208.00–$219.28.

What is the P/E ratio for ASND?

The P/E ratio (Price-to-Earnings) for ASND is shown in the Key Statistics section. This valuation metric helps compare Ascendis Pharma A/S to industry peers.

Does ASND pay dividends?

Ascendis Pharma A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ASND?

Based on 9 analysts, the consensus for ASND is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ASND?

Ascendis Pharma A/S's market capitalization is $13.07B, classifying it as a large-cap company. Ascendis Pharma A/S operates in the Healthcare sector within the Biotechnology industry.